These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36915060)

  • 1. Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema.
    Koc H; Alpay A; Ugurbas SH
    BMC Ophthalmol; 2023 Mar; 23(1):97. PubMed ID: 36915060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India.
    Chakraborty D; Mondal S; Sengupta S; Maiti A; Boral S; Das A; Sinha TK; Nandi K
    Indian J Ophthalmol; 2024 Jul; 72(7):1001-1006. PubMed ID: 38622856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
    Mishra SK; Sinha S; Chauhan R; Kumar A
    Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Intravitreal Dexamethasone Implant and Posterior Subtenon Triamcinolone Injection in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.
    Gumus G; Erdogan G; Gunay BO; Karatas Durusoy G
    Ophthalmologica; 2022; 245(5):439-445. PubMed ID: 35921811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of dexamethasone implants in treating diabetic macular edema with hard exudates: a clinical observation.
    Zhao S; Liang X; Zhang J
    Int Ophthalmol; 2024 Sep; 44(1):377. PubMed ID: 39256259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
    Arıkan Yorgun M; Toklu Y; Mutlu M
    Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of intravitreal dexamethasone implant as a starting monotherapy and when switching from an anti-VEGF drug in diabetic macular edema].
    Bikbov MM; Zainullin RM; Kudoyarova KI; Kalanov MR
    Vestn Oftalmol; 2021; 137(6):5-11. PubMed ID: 34965061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema.
    Mahapatra SK; Parhi A; Shree P; Mohanty A
    Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S106-S110. PubMed ID: 38131551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early treatment with dexamethasone intravitreal implants in diabetic macular edema: Naïve versus refractory patients.
    Bux AV; Fortunato F; Barone A; Russo V; Delle Noci N; Iaculli C
    Eur J Ophthalmol; 2022 May; 32(3):1619-1626. PubMed ID: 34120496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis.
    Ji K; Zhang Q; Tian M; Xing Y
    Medicine (Baltimore); 2019 May; 98(22):e15798. PubMed ID: 31145307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
    Kaldırım H; Savur F; Kırgız A; Atalay K
    Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    He Y; Ren XJ; Hu BJ; Lam WC; Li XR
    BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Dexamethasone in Diabetic Macular Oedema: A Way of Enhancing the Response to Anti-VEGF in Non- or Poor Responders?
    Touhami S; Dupas B; Bertaud S; Tadayoni R; Couturier A
    Ophthalmologica; 2022; 245(4):350-357. PubMed ID: 34587614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?
    Çakmak S; Demir G; Tunç U; Sukun EY; Akbas YB; Ozkaya A; Artunay O; Erdogan G
    Arq Bras Oftalmol; 2024; 88(2):e20230229. PubMed ID: 39319910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.